Partnering Opportunities

• Genetic Diseases

  Novel Treatment to Ensure Efficacious Dosage for Multiple, Rare Genetic Diseases

  Optimal dosing regimen for treating seizures and self-aggressive behavior

• Anti-Aging

  Cell Longevity Treatment with a Cdc42 specific inhibitor

  CASIN significantly increases murine lifespan and epigenetic clock.

• Pulmonology

  Airway Clearance Technology for Patients with Chronic Lung Diseases

  Rapid and highly effective mucus clearance from airways without active coughing.

• Oncology

  Small Molecule Vav3 inhibitor as Novel Cancer Therapeutic

  Our proprietary inhibitor binds to Vav3 thereby inhibiting the activation of Rac and the estrogen receptor.

• Gene and Cell therapy

  Stem Cell & Organoid Medicine

  Organoids provide an unprecedented opportunity to study human organ development and physiology, and investigate the cause of disease.

• Genetics Immunology

  Complement 5a increases inflammation in Hunter Syndrome

  Complement 5a increases inflammation in Hunter Syndrome

• Pulmonology

  Repurposing Barasertib for Idiopathic Pulmonary Fibrosis

  Repurposing a phase I/II compound (AURKB inhibitor - barasertib) for idiopathic pulmonary fibrosis therapy.

• Immunology

  CAR-NK Therapy for Lupus

  Human Natural Killer cells expressing chimeric antigen receptor that targets aberrant immune system signaling that is involved in auto-antibody production associated with Systemic Lupus Erythematosus.

• Neurodegenerative Diseases

  Restoring acid-β-glucosidase activity by non-inhibitory small molecule chaperones

  Restore GCase activity in the brain for Gaucher and Parkinson's

• Neurology

  Multi-Frequency Encoded Source Imaging

  A new imaging technology to localize and visualize electrical and/or magnetic signals in two or more frequency ranges.